|
시장보고서
상품코드
1571360
맞춤형 항체 서비스 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 제품 유형별, 서비스 유형별, 용도별, 적응증별, 공급원별, 최종사용자별, 지역별Custom Antibody Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Service Type, Application, Disease Indication, Source, End User, and Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
맞춤형 항체 서비스 시장 규모는 2023년 5억 9,033만 달러에서 2031년 12억 1,635만 달러로 2023-2031년 9.5%의 CAGR로 성장할 것으로 예측됩니다. 만성 질환의 유병률 증가와 바이오시밀러의 승인 증가는 맞춤형 항체 서비스 시장 규모 확대에 기여하는 주목할 만한 요인입니다. 그러나 유전자 변형 동물을 이용한 항체 생산과 관련된 높은 비용과 복잡성은 맞춤형 항체 서비스 시장의 성장을 저해하는 요인으로 작용하고 있습니다.
재조합 항체 공학은 의약품 개발자와 연구자들이 특정 질병 치료에 이상적인 특정 속성을 가진 분자를 만들어 낼 수 있는 광범위한 잠재력을 가지고 있습니다. 이미 몇몇 제약회사들은 항체 서열에서 잠재적인 치료제를 예측하고 분석하는 데 AI 기술을 활용하고 있으며, 생산에 들어가기 전에 알고리즘을 통해 잠재력을 평가하고 있습니다. 예를 들어, 파운데이션 메디슨(Foundation Medicine)은 고형암, 혈액암, 육종에 대한 차세대 시퀀싱 기술 기반의 유전체 프로파일링 분석을 개발, 제조 및 판매하고 있으며, 환자를 표적치료, 면역치료, 임상시험 옵션에 맞게 조정하는 데 활용할 수 있습니다. 또한 바이오 제약 업계와 협력하여 환자를 위한 차세대 혁신적 치료법의 발견, 개발 및 유통을 지원하고 있으며, 의약품 디스커버리 캐터펄트(The Medicines Discovery Catapult)는 암 치료를 위한 새로운 분자를 식별하기 위해 인실리코 파이프라인을(컴퓨터로) 테스트하고 있습니다. 예를 들어, AI를 적용하여 새로운 드라이버 유전자나 폐암 치료제 후보를 찾을 수 있습니다. 이처럼 재조합 항체를 이용한 기술의 발전은 향후 몇 년 동안 맞춤형 항체 서비스 시장에 새로운 트렌드를 가져올 것으로 예상됩니다.
용도별 인사이트
맞춤형 항체 서비스 시장은 용도별로 면역조직화학, 웨스턴 블롯 및 IP, ELISA, 형광 활성화 세포 분류, 질량 분석, 기타 활동으로 분류되며, 2023년 맞춤형 항체 서비스 시장에서 가장 큰 점유율을 차지한 부문은 ELISA 부문입니다. 효소 결합 면역 흡착 분석법(ELISA)은 개인의 혈액에서 항체를 검출하고 측정하는 검사법입니다. 특정 감염과 관련된 항체를 가지고 있는지 여부를 판단하는 데 사용됩니다. ELISA는 생체 시료에서 항체, 항원, 단백질, 당단백질을 측정하는 면역학적 검사로, HIV 감염 진단, 임신 검사, 세포 상청액 및 혈청 내 사이토카인 및 수용성 수용체 측정 등이 그 예입니다. 단클론항체는 단일 B세포 클론에 의해 생산되며, 항원의 단일 에피토프를 표적으로 삼습니다. 단클론항체는 신속하고 신뢰할 수 있는 ELISA 검사 등 의료 진단에 사용될 수 있으며, ELISA는 시료 내 분석 대상의 존재 여부를 정성적으로 나타낼 뿐만 아니라 다수의 시료 내 단백질과 펩타이드의 절대량을 측정할 수 있어 면역조직화학(IHC), 면역세포화학(ICC), 서양화학(Western blot), 면역조직화학(IHC) 화학(ICC), 웨스턴블롯 등 관련 기술에 비해 강력한 우위를 가지고 있습니다.
미국 질병통제예방센터(Centers for Disease Control and Prevention), 국제당뇨병연맹(International Diabetes Federation), 미국암협회(American Cancer Society) 등은 맞춤형 항체 서비스 시장 보고서를 작성할 때 참조한 1차 및 2차 정보 중 하나입니다.
목차
제1장 소개
제2장 주요 요약
- 주요 인사이트
제3장 조사 방법
- 2차 조사
- 1차 조사
- 가설 책정
- 거시경제 요인 분석
- 기초 수치 작성
- 데이터 삼각측량
- 국가 레벨 데이터
제4장 맞춤형 항체 서비스 시장 상황
- PEST 분석
제5장 맞춤형 항체 서비스 시장 : 주요 시장 역학
- 맞춤형 항체 서비스 시장 - 주요 시장 역학
- 시장 성장 촉진요인
- 만성질환 증가
- 바이오시밀러 승인 증가
- 시장 성장 억제요인
- 유전자 재조합 동물을 이용한 항체 제작에 따른 고비용과 복잡성
- 시장 기회
- 신흥 경제 국가 및 선진 경제 국가의 정부 연구개발 활동 활발화
- 향후 동향
- 재조합 항체를 이용한 기술의 진보
- 성장 촉진요인과 저해요인의 영향
제6장 맞춤형 항체 서비스 시장 : 세계 시장 분석
- 맞춤형 항체 서비스 시장 매출, 2021-2031년
- 맞춤형 항체 서비스 세계 시장 예측 분석
제7장 맞춤형 항체 서비스 시장 : 최종사용자별
- 생명과학 산업
- 제약·바이오테크놀러지 기업
- 학술·연구기관
- 수탁연구기관
제8장 맞춤형 항체 서비스 시장 : 적응 질환별
- 종양
- 감염증
- 면역학
- 심혈관질환
- 기타
제9장 맞춤형 항체 서비스 시장 : 공급원별
- 치킨
- 토끼
- 래트
- 몰모트
- 마우스 또는 인간화 마우스
- 기타
제10장 맞춤형 항체 서비스 시장 : 용도별
- 면역조직화학(IHC)
- 웨스턴 블롯 및 IP
- ELISA법
- 형광 활성화 세포 선별(FACS)
- 질량 분석
- 기타
제11장 맞춤형 항체 서비스 시장 : 서비스 유형별
- 항체 탐색·개발
- 항체 제작 서비스
- 기타
제12장 맞춤형 항체 서비스 시장 : 제품 유형별
- 단클론
- 다클론 하이브리도마
- 재조합 항체
- 기타
제13장 맞춤형 항체 서비스 시장 : 지역별
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 일본
- 중국
- 인도
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카
- 중남미
- 브라질
- 아르헨티나
- 기타 중남미
제14장 맞춤형 항체 서비스 시장 : 업계 상황
- 맞춤형 항체 서비스 시장의 성장 전략
- 유기적 성장 전략
- 무기적 성장 전략
- 성장 전략
제15장 기업 개요
- Thermo Fisher Scientific Inc
- Sino Biological Inc.
- GenScript Biotech Corporation
- Biochain Incorporated
- R&D Systems, Inc
- Kaneka Eurogentec S.A.
- Fortis Life Sciences
- Precision Antibody(A&G Pharmaceutical, Inc.)
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Abgenex
- Creative Biolabs Inc
- Agilent Technologies Inc
- Bioklone
- Scantibodies Laboratory, Inc.
제16장 부록
ksm 24.10.25The custom antibody services market size is expected to grow from US$ 590.33 million in 2023 to US$ 1,216.35 million by 2031; it is projected to register a CAGR of 9.5% during 2023-2031. The increasing prevalence of chronic diseases and rising approvals of biosimilars are noteworthy factors contributing to the expansion of the custom antibody services market size. However, the high costs and complexities associated with antibody production using transgenic animals hinders the custom antibody services market growth.
Recombinant antibody engineering has a wide scope of potential for drug developers and researchers to create specific molecules with specific attributes ideally suited for treating specific diseases. Several drug developers are already using AI technologies in the prediction and analysis of potential therapeutics from antibody sequences, using algorithms to assess their potential before production has commenced. For instance, Foundation Medicine develops, manufactures, and sells genomic profiling assays on the basis of next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas that can be utilized to match patients with targeted therapies, immunotherapies, and clinical trial options. Such companies also partner with the biopharma industry to help discover, develop, and distribute the next breakthrough treatments for patients. The Medicines Discovery Catapult is testing (on a computer) an in-silico pipeline for identifying new molecules for cancer treatment; for example, applying AI to find new disease drivers as well as candidate drugs for lung cancer. Thus, technological advancements using recombinant antibodies are expected to bring new trends into the custom antibody services market in the coming years.
Application -Based Insights
Based on application, the custom antibody services market is segmented into immunohistochemistry, western blot and IP, ELISA, fluorescence-activated cell sorting, mass spectrometry, and others. The ELISA segment held the largest custom antibody services market share in 2023. Enzyme-linked immunosorbent assay (ELISA) is a test that detects and measures antibodies in an individual's blood. It can be used to determine if a person has antibodies related to certain infectious conditions. A few examples of these infections include bacterial, viral, or fungal infections. ELISA is an immunological assay that helps measure antibodies, antigens, proteins, and glycoproteins in biological samples. A few examples include the diagnosis of HIV infection, pregnancy tests, and measurement of cytokines or soluble receptors in cell supernatant or serum. Monoclonal antibodies are produced by a single B-cell clone and target a single epitope on an antigen. They can be used in medical diagnoses, including ELISA tests, which are quick and reliable. In addition to qualitative indications of the presence or absence of an analyte in a sample, ELISAs can provide a measurement of absolute levels of protein or peptide in a large number of samples, giving it a strong advantage over related techniques such as immunohistochemistry (IHC), immunocytochemistry (ICC), or western blot.
The Centers for Disease Control and Prevention, the International Diabetes Federation, and American Cancer Society are among the primary and secondary sources referred to while preparing the custom antibody services market report.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Custom Antibody Services Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
5. Custom Antibody Services Market - Key Market Dynamics
- 5.1 Custom Antibody Services Market - Key Market Dynamics
- 5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Chronic Diseases
- 5.2.2 Rising Approvals of Biosimilars
- 5.3 Market Restraints
- 5.3.1 High Costs and Complexities Associated with Antibody Production Using Transgenic Animals
- 5.4 Market Opportunities
- 5.4.1 Rise in Government Research and Development Activities in Emerging and Developed Economies
- 5.5 Future Trends
- 5.5.1 Technological Advancements Using Recombinant Antibodies
- 5.6 Impact of Drivers and Restraints:
6. Custom Antibody Services Market - Global Market Analysis
- 6.1 Custom Antibody Services Market Revenue (US$ Million), 2021-2031
- 6.2 Global Custom Antibody Services Market Forecast Analysis
7. Custom Antibody Services Market Analysis - by End User
- 7.1 Life Science Industry
- 7.1.1 Overview
- 7.1.2 Life Science Industry: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.2 Pharmaceutical and Biotech Companies
- 7.2.1 Overview
- 7.2.2 Pharmaceutical and Biotech Companies: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.3 Academic and Research Institutes
- 7.3.1 Overview
- 7.3.2 Academic and Research Institutes: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.4 Contract Research Organizations
- 7.4.1 Overview
- 7.4.2 Contract Research Organizations: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
8. Custom Antibody Services Market Analysis - by Disease Indication
- 8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.2 Infectious Diseases
- 8.2.1 Overview
- 8.2.2 Infectious Diseases: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.3 Immunology
- 8.3.1 Overview
- 8.3.2 Immunology: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.4 Cardiovascular Diseases
- 8.4.1 Overview
- 8.4.2 Cardiovascular Diseases: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
9. Custom Antibody Services Market Analysis - by Source
- 9.1 Chicken
- 9.1.1 Overview
- 9.1.2 Chicken: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2 Rabbits
- 9.2.1 Overview
- 9.2.2 Rabbits: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3 Rats
- 9.3.1 Overview
- 9.3.2 Rats: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 9.4 Guinea Pigs
- 9.4.1 Overview
- 9.4.2 Guinea Pigs: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 9.5 Mouse or Humanized Mice
- 9.5.1 Overview
- 9.5.2 Mouse or Humanized Mice: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
10. Custom Antibody Services Market Analysis - by Application
- 10.1 Immunohistochemistry (IHC)
- 10.1.1 Overview
- 10.1.2 Immunohistochemistry (IHC): Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2 Western Blot and IP
- 10.2.1 Overview
- 10.2.2 Western Blot and IP: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3 ELISA
- 10.3.1 Overview
- 10.3.2 ELISA: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4 Fluorescence-activated cell sorting (FACS)
- 10.4.1 Overview
- 10.4.2 Fluorescence-activated cell sorting (FACS): Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5 Mass Spectrometry
- 10.5.1 Overview
- 10.5.2 Mass Spectrometry: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
11. Custom Antibody Services Market Analysis - by Service Type
- 11.1 Antibody Discovery and Development
- 11.1.1 Overview
- 11.1.2 Antibody Discovery and Development: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2 Antibody Production Services
- 11.2.1 Overview
- 11.2.2 Antibody Production Services: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.3 Others
- 11.3.1 Overview
- 11.3.2 Others: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
12. Custom Antibody Services Market Analysis - by Product Type
- 12.1 Monoclonal
- 12.1.1 Overview
- 12.1.2 Monoclonal: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2 Polyclonal hybridoma
- 12.2.1 Overview
- 12.2.2 Polyclonal hybridoma: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3 Recombinant antibody
- 12.3.1 Overview
- 12.3.2 Recombinant antibody: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4 Others
- 12.4.1 Overview
- 12.4.2 Others: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
13. Custom Antibody Services Market - Geographical Analysis
- 13.1 Overview
- 13.2 North America
- 13.2.1 North America Custom Antibody Services Market Overview
- 13.2.2 North America: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.2.2.1 North America: Custom Antibody Services Market - Revenue and Forecast Analysis - by End User
- 13.2.2.2 North America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Disease Indication
- 13.2.2.3 North America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Source
- 13.2.2.3.1 North America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Mouse Or Humanized Mice
- 13.2.2.4 North America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Application
- 13.2.2.5 North America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Service Type
- 13.2.2.6 North America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Product Type
- 13.2.3 North America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
- 13.2.3.1 United States: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.2.3.1.1 United States: Custom Antibody Services Market Breakdown, by End User
- 13.2.3.1.2 United States: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.2.3.1.3 United States: Custom Antibody Services Market Breakdown, by Source
- 13.2.3.1.3.1 United States: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.2.3.1.4 United States: Custom Antibody Services Market Breakdown, by Application
- 13.2.3.1.5 United States: Custom Antibody Services Market Breakdown, by Service Type
- 13.2.3.1.6 United States: Custom Antibody Services Market Breakdown, by Product Type
- 13.2.3.2 Canada: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.2.3.2.1 Canada: Custom Antibody Services Market Breakdown, by End User
- 13.2.3.2.2 Canada: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.2.3.2.3 Canada: Custom Antibody Services Market Breakdown, by Source
- 13.2.3.2.3.1 Canada: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.2.3.2.4 Canada: Custom Antibody Services Market Breakdown, by Application
- 13.2.3.2.5 Canada: Custom Antibody Services Market Breakdown, by Service Type
- 13.2.3.2.6 Canada: Custom Antibody Services Market Breakdown, by Product Type
- 13.2.3.3 Mexico: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.2.3.3.1 Mexico: Custom Antibody Services Market Breakdown, by End User
- 13.2.3.3.2 Mexico: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.2.3.3.3 Mexico: Custom Antibody Services Market Breakdown, by Source
- 13.2.3.3.3.1 Mexico: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.2.3.3.4 Mexico: Custom Antibody Services Market Breakdown, by Application
- 13.2.3.3.5 Mexico: Custom Antibody Services Market Breakdown, by Service Type
- 13.2.3.3.6 Mexico: Custom Antibody Services Market Breakdown, by Product Type
- 13.2.3.1 United States: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3 Europe
- 13.3.1 Europe Custom Antibody Services Market Overview
- 13.3.2 Europe: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.2.1 Europe: Custom Antibody Services Market - Revenue and Forecast Analysis - by End User
- 13.3.2.2 Europe: Custom Antibody Services Market - Revenue and Forecast Analysis - by Disease Indication
- 13.3.2.3 Europe: Custom Antibody Services Market - Revenue and Forecast Analysis - by Source
- 13.3.2.3.1 Europe: Custom Antibody Services Market - Revenue and Forecast Analysis - by Mouse Or Humanized Mice
- 13.3.2.4 Europe: Custom Antibody Services Market - Revenue and Forecast Analysis - by Application
- 13.3.2.5 Europe: Custom Antibody Services Market - Revenue and Forecast Analysis - by Service Type
- 13.3.2.6 Europe: Custom Antibody Services Market - Revenue and Forecast Analysis - by Product Type
- 13.3.3 Europe: Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
- 13.3.3.1 United Kingdom: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.3.1.1 United Kingdom: Custom Antibody Services Market Breakdown, by End User
- 13.3.3.1.2 United Kingdom: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.3.3.1.3 United Kingdom: Custom Antibody Services Market Breakdown, by Source
- 13.3.3.1.3.1 United Kingdom: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.3.3.1.4 United Kingdom: Custom Antibody Services Market Breakdown, by Application
- 13.3.3.1.5 United Kingdom: Custom Antibody Services Market Breakdown, by Service Type
- 13.3.3.1.6 United Kingdom: Custom Antibody Services Market Breakdown, by Product Type
- 13.3.3.2 Germany: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.3.2.1 Germany: Custom Antibody Services Market Breakdown, by End User
- 13.3.3.2.2 Germany: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.3.3.2.3 Germany: Custom Antibody Services Market Breakdown, by Source
- 13.3.3.2.3.1 Germany: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.3.3.2.4 Germany: Custom Antibody Services Market Breakdown, by Application
- 13.3.3.2.5 Germany: Custom Antibody Services Market Breakdown, by Service Type
- 13.3.3.2.6 Germany: Custom Antibody Services Market Breakdown, by Product Type
- 13.3.3.3 France: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.3.3.1 France: Custom Antibody Services Market Breakdown, by End User
- 13.3.3.3.2 France: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.3.3.3.3 France: Custom Antibody Services Market Breakdown, by Source
- 13.3.3.3.3.1 France: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.3.3.3.4 France: Custom Antibody Services Market Breakdown, by Application
- 13.3.3.3.5 France: Custom Antibody Services Market Breakdown, by Service Type
- 13.3.3.3.6 France: Custom Antibody Services Market Breakdown, by Product Type
- 13.3.3.4 Italy: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.3.4.1 Italy: Custom Antibody Services Market Breakdown, by End User
- 13.3.3.4.2 Italy: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.3.3.4.3 Italy: Custom Antibody Services Market Breakdown, by Source
- 13.3.3.4.3.1 Italy: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.3.3.4.4 Italy: Custom Antibody Services Market Breakdown, by Application
- 13.3.3.4.5 Italy: Custom Antibody Services Market Breakdown, by Service Type
- 13.3.3.4.6 Italy: Custom Antibody Services Market Breakdown, by Product Type
- 13.3.3.5 Spain: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.3.5.1 Spain: Custom Antibody Services Market Breakdown, by End User
- 13.3.3.5.2 Spain: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.3.3.5.3 Spain: Custom Antibody Services Market Breakdown, by Source
- 13.3.3.5.3.1 Spain: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.3.3.5.4 Spain: Custom Antibody Services Market Breakdown, by Application
- 13.3.3.5.5 Spain: Custom Antibody Services Market Breakdown, by Service Type
- 13.3.3.5.6 Spain: Custom Antibody Services Market Breakdown, by Product Type
- 13.3.3.6 Rest of Europe: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.3.6.1 Rest of Europe: Custom Antibody Services Market Breakdown, by End User
- 13.3.3.6.2 Rest of Europe: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.3.3.6.3 Rest of Europe: Custom Antibody Services Market Breakdown, by Source
- 13.3.3.6.3.1 Rest of Europe: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.3.3.6.4 Rest of Europe: Custom Antibody Services Market Breakdown, by Application
- 13.3.3.6.5 Rest of Europe: Custom Antibody Services Market Breakdown, by Service Type
- 13.3.3.6.6 Rest of Europe: Custom Antibody Services Market Breakdown, by Product Type
- 13.3.3.1 United Kingdom: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4 Asia Pacific
- 13.4.1 Asia Pacific Custom Antibody Services Market Overview
- 13.4.2 Asia Pacific: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.2.1 Asia Pacific: Custom Antibody Services Market - Revenue and Forecast Analysis - by End User
- 13.4.2.2 Asia Pacific: Custom Antibody Services Market - Revenue and Forecast Analysis - by Disease Indication
- 13.4.2.3 Asia Pacific: Custom Antibody Services Market - Revenue and Forecast Analysis - by Source
- 13.4.2.3.1 Asia Pacific: Custom Antibody Services Market - Revenue and Forecast Analysis - by Mouse Or Humanized Mice
- 13.4.2.4 Asia Pacific: Custom Antibody Services Market - Revenue and Forecast Analysis - by Application
- 13.4.2.5 Asia Pacific: Custom Antibody Services Market - Revenue and Forecast Analysis - by Service Type
- 13.4.2.6 Asia Pacific: Custom Antibody Services Market - Revenue and Forecast Analysis - by Product Type
- 13.4.3 Asia Pacific: Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
- 13.4.3.1 Japan: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.3.1.1 Japan: Custom Antibody Services Market Breakdown, by End User
- 13.4.3.1.2 Japan: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.4.3.1.3 Japan: Custom Antibody Services Market Breakdown, by Source
- 13.4.3.1.3.1 Japan: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.4.3.1.4 Japan: Custom Antibody Services Market Breakdown, by Application
- 13.4.3.1.5 Japan: Custom Antibody Services Market Breakdown, by Service Type
- 13.4.3.1.6 Japan: Custom Antibody Services Market Breakdown, by Product Type
- 13.4.3.2 China: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.3.2.1 China: Custom Antibody Services Market Breakdown, by End User
- 13.4.3.2.2 China: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.4.3.2.3 China: Custom Antibody Services Market Breakdown, by Source
- 13.4.3.2.3.1 China: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.4.3.2.4 China: Custom Antibody Services Market Breakdown, by Application
- 13.4.3.2.5 China: Custom Antibody Services Market Breakdown, by Service Type
- 13.4.3.2.6 China: Custom Antibody Services Market Breakdown, by Product Type
- 13.4.3.3 India: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.3.3.1 India: Custom Antibody Services Market Breakdown, by End User
- 13.4.3.3.2 India: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.4.3.3.3 India: Custom Antibody Services Market Breakdown, by Source
- 13.4.3.3.3.1 India: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.4.3.3.4 India: Custom Antibody Services Market Breakdown, by Application
- 13.4.3.3.5 India: Custom Antibody Services Market Breakdown, by Service Type
- 13.4.3.3.6 India: Custom Antibody Services Market Breakdown, by Product Type
- 13.4.3.4 South Korea: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.3.4.1 South Korea: Custom Antibody Services Market Breakdown, by End User
- 13.4.3.4.2 South Korea: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.4.3.4.3 South Korea: Custom Antibody Services Market Breakdown, by Source
- 13.4.3.4.3.1 South Korea: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.4.3.4.4 South Korea: Custom Antibody Services Market Breakdown, by Application
- 13.4.3.4.5 South Korea: Custom Antibody Services Market Breakdown, by Service Type
- 13.4.3.4.6 South Korea: Custom Antibody Services Market Breakdown, by Product Type
- 13.4.3.5 Australia: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.3.5.1 Australia: Custom Antibody Services Market Breakdown, by End User
- 13.4.3.5.2 Australia: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.4.3.5.3 Australia: Custom Antibody Services Market Breakdown, by Source
- 13.4.3.5.3.1 Australia: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.4.3.5.4 Australia: Custom Antibody Services Market Breakdown, by Application
- 13.4.3.5.5 Australia: Custom Antibody Services Market Breakdown, by Service Type
- 13.4.3.5.6 Australia: Custom Antibody Services Market Breakdown, by Product Type
- 13.4.3.6 Rest of APAC: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.3.6.1 Rest of APAC: Custom Antibody Services Market Breakdown, by End User
- 13.4.3.6.2 Rest of APAC: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.4.3.6.3 Rest of APAC: Custom Antibody Services Market Breakdown, by Source
- 13.4.3.6.3.1 Rest of APAC: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.4.3.6.4 Rest of APAC: Custom Antibody Services Market Breakdown, by Application
- 13.4.3.6.5 Rest of APAC: Custom Antibody Services Market Breakdown, by Service Type
- 13.4.3.6.6 Rest of APAC: Custom Antibody Services Market Breakdown, by Product Type
- 13.4.3.1 Japan: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5 Middle East and Africa
- 13.5.1 Middle East and Africa Custom Antibody Services Market Overview
- 13.5.2 Middle East and Africa: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.2.1 Middle East and Africa: Custom Antibody Services Market - Revenue and Forecast Analysis - by End User
- 13.5.2.2 Middle East and Africa: Custom Antibody Services Market - Revenue and Forecast Analysis - by Disease Indication
- 13.5.2.3 Middle East and Africa: Custom Antibody Services Market - Revenue and Forecast Analysis - by Source
- 13.5.2.3.1 Middle East and Africa: Custom Antibody Services Market - Revenue and Forecast Analysis - by Mouse Or Humanized Mice
- 13.5.2.4 Middle East and Africa: Custom Antibody Services Market - Revenue and Forecast Analysis - by Application
- 13.5.2.5 Middle East and Africa: Custom Antibody Services Market - Revenue and Forecast Analysis - by Service Type
- 13.5.2.6 Middle East and Africa: Custom Antibody Services Market - Revenue and Forecast Analysis - by Product Type
- 13.5.3 Middle East and Africa: Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
- 13.5.3.1 Saudi Arabia: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.3.1.1 Saudi Arabia: Custom Antibody Services Market Breakdown, by End User
- 13.5.3.1.2 Saudi Arabia: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.5.3.1.3 Saudi Arabia: Custom Antibody Services Market Breakdown, by Source
- 13.5.3.1.3.1 Saudi Arabia: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.5.3.1.4 Saudi Arabia: Custom Antibody Services Market Breakdown, by Application
- 13.5.3.1.5 Saudi Arabia: Custom Antibody Services Market Breakdown, by Service Type
- 13.5.3.1.6 Saudi Arabia: Custom Antibody Services Market Breakdown, by Product Type
- 13.5.3.2 South Africa: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.3.2.1 South Africa: Custom Antibody Services Market Breakdown, by End User
- 13.5.3.2.2 South Africa: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.5.3.2.3 South Africa: Custom Antibody Services Market Breakdown, by Source
- 13.5.3.2.3.1 South Africa: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.5.3.2.4 South Africa: Custom Antibody Services Market Breakdown, by Application
- 13.5.3.2.5 South Africa: Custom Antibody Services Market Breakdown, by Service Type
- 13.5.3.2.6 South Africa: Custom Antibody Services Market Breakdown, by Product Type
- 13.5.3.3 United Arab Emirates: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.3.3.1 United Arab Emirates: Custom Antibody Services Market Breakdown, by End User
- 13.5.3.3.2 United Arab Emirates: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.5.3.3.3 United Arab Emirates: Custom Antibody Services Market Breakdown, by Source
- 13.5.3.3.3.1 United Arab Emirates: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.5.3.3.4 United Arab Emirates: Custom Antibody Services Market Breakdown, by Application
- 13.5.3.3.5 United Arab Emirates: Custom Antibody Services Market Breakdown, by Service Type
- 13.5.3.3.6 United Arab Emirates: Custom Antibody Services Market Breakdown, by Product Type
- 13.5.3.4 Rest of Middle East and Africa: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.3.4.1 Rest of Middle East and Africa: Custom Antibody Services Market Breakdown, by End User
- 13.5.3.4.2 Rest of Middle East and Africa: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.5.3.4.3 Rest of Middle East and Africa: Custom Antibody Services Market Breakdown, by Source
- 13.5.3.4.3.1 Rest of Middle East and Africa: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.5.3.4.4 Rest of Middle East and Africa: Custom Antibody Services Market Breakdown, by Application
- 13.5.3.4.5 Rest of Middle East and Africa: Custom Antibody Services Market Breakdown, by Service Type
- 13.5.3.4.6 Rest of Middle East and Africa: Custom Antibody Services Market Breakdown, by Product Type
- 13.5.3.1 Saudi Arabia: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.6 South and Central America
- 13.6.1 South and Central America Custom Antibody Services Market Overview
- 13.6.2 South and Central America: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.6.2.1 South and Central America: Custom Antibody Services Market - Revenue and Forecast Analysis - by End User
- 13.6.2.2 South and Central America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Disease Indication
- 13.6.2.3 South and Central America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Source
- 13.6.2.3.1 South and Central America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Mouse Or Humanized Mice
- 13.6.2.4 South and Central America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Application
- 13.6.2.5 South and Central America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Service Type
- 13.6.2.6 South and Central America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Product Type
- 13.6.3 South and Central America: Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
- 13.6.3.1 Brazil: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.6.3.1.1 Brazil: Custom Antibody Services Market Breakdown, by End User
- 13.6.3.1.2 Brazil: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.6.3.1.3 Brazil: Custom Antibody Services Market Breakdown, by Source
- 13.6.3.1.3.1 Brazil: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.6.3.1.4 Brazil: Custom Antibody Services Market Breakdown, by Application
- 13.6.3.1.5 Brazil: Custom Antibody Services Market Breakdown, by Service Type
- 13.6.3.1.6 Brazil: Custom Antibody Services Market Breakdown, by Product Type
- 13.6.3.2 Argentina: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.6.3.2.1 Argentina: Custom Antibody Services Market Breakdown, by End User
- 13.6.3.2.2 Argentina: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.6.3.2.3 Argentina: Custom Antibody Services Market Breakdown, by Source
- 13.6.3.2.3.1 Argentina: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.6.3.2.4 Argentina: Custom Antibody Services Market Breakdown, by Application
- 13.6.3.2.5 Argentina: Custom Antibody Services Market Breakdown, by Service Type
- 13.6.3.2.6 Argentina: Custom Antibody Services Market Breakdown, by Product Type
- 13.6.3.3 Rest of South and Central America: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
- 13.6.3.3.1 Rest of South and Central America: Custom Antibody Services Market Breakdown, by End User
- 13.6.3.3.2 Rest of South and Central America: Custom Antibody Services Market Breakdown, by Disease Indication
- 13.6.3.3.3 Rest of South and Central America: Custom Antibody Services Market Breakdown, by Source
- 13.6.3.3.3.1 Rest of South and Central America: Custom Antibody Services Market Breakdown, by Mouse Or Humanized Mice
- 13.6.3.3.4 Rest of South and Central America: Custom Antibody Services Market Breakdown, by Application
- 13.6.3.3.5 Rest of South and Central America: Custom Antibody Services Market Breakdown, by Service Type
- 13.6.3.3.6 Rest of South and Central America: Custom Antibody Services Market Breakdown, by Product Type
- 13.6.3.1 Brazil: Custom Antibody Services Market - Revenue and Forecast to 2031 (US$ Million)
14. Custom Antibody Services Market - Industry Landscape
- 14.1 Overview
- 14.2 Growth Strategies in Custom Antibody Services Market
- 14.3 Organic Growth Strategies
- 14.3.1 Overview
- 14.4 Inorganic Growth Strategies
- 14.4.1 Overview
15. Company Profiles
- 15.1 Thermo Fisher Scientific Inc
- 15.1.1 Key Facts
- 15.1.2 Business Description
- 15.1.3 Products and Services
- 15.1.4 Financial Overview
- 15.1.5 SWOT Analysis
- 15.1.6 Key Developments
- 15.2 Sino Biological Inc.
- 15.2.1 Key Facts
- 15.2.2 Business Description
- 15.2.3 Products and Services
- 15.2.4 Financial Overview
- 15.2.5 SWOT Analysis
- 15.2.6 Key Developments
- 15.3 GenScript Biotech Corporation
- 15.3.1 Key Facts
- 15.3.2 Business Description
- 15.3.3 Products and Services
- 15.3.4 Financial Overview
- 15.3.5 SWOT Analysis
- 15.3.6 Key Developments
- 15.4 Biochain Incorporated
- 15.4.1 Key Facts
- 15.4.2 Business Description
- 15.4.3 Products and Services
- 15.4.4 Financial Overview
- 15.4.5 SWOT Analysis
- 15.4.6 Key Developments
- 15.5 R&D Systems, Inc
- 15.5.1 Key Facts
- 15.5.2 Business Description
- 15.5.3 Products and Services
- 15.5.4 Financial Overview
- 15.5.5 SWOT Analysis
- 15.5.6 Key Developments
- 15.6 Kaneka Eurogentec S.A.
- 15.6.1 Key Facts
- 15.6.2 Business Description
- 15.6.3 Products and Services
- 15.6.4 Financial Overview
- 15.6.5 SWOT Analysis
- 15.6.6 Key Developments
- 15.7 Fortis Life Sciences
- 15.7.1 Key Facts
- 15.7.2 Business Description
- 15.7.3 Products and Services
- 15.7.4 Financial Overview
- 15.7.5 SWOT Analysis
- 15.7.6 Key Developments
- 15.8 Precision Antibody (A&G Pharmaceutical, Inc.)
- 15.8.1 Key Facts
- 15.8.2 Business Description
- 15.8.3 Products and Services
- 15.8.4 Financial Overview
- 15.8.5 SWOT Analysis
- 15.8.6 Key Developments
- 15.9 Biocytogen Pharmaceuticals Beijing Co Ltd
- 15.9.1 Key Facts
- 15.9.2 Business Description
- 15.9.3 Products and Services
- 15.9.4 Financial Overview
- 15.9.5 SWOT Analysis
- 15.9.6 Key Developments
- 15.10 Abgenex
- 15.10.1 Key Facts
- 15.10.2 Business Description
- 15.10.3 Products and Services
- 15.10.4 Financial Overview
- 15.10.5 SWOT Analysis
- 15.10.6 Key Developments
- 15.11 Creative Biolabs Inc
- 15.11.1 Key Facts
- 15.11.2 Business Description
- 15.11.3 Products and Services
- 15.11.4 Financial Overview
- 15.11.5 SWOT Analysis
- 15.11.6 Key Developments
- 15.12 Agilent Technologies Inc
- 15.12.1 Key Facts
- 15.12.2 Business Description
- 15.12.3 Products and Services
- 15.12.4 Financial Overview
- 15.12.5 SWOT Analysis
- 15.12.6 Key Developments
- 15.13 Bioklone
- 15.13.1 Key Facts
- 15.13.2 Business Description
- 15.13.3 Products and Services
- 15.13.4 Financial Overview
- 15.13.5 SWOT Analysis
- 15.13.6 Key Developments
- 15.14 Scantibodies Laboratory, Inc.
- 15.14.1 Key Facts
- 15.14.2 Business Description
- 15.14.3 Products and Services
- 15.14.4 Financial Overview
- 15.14.5 SWOT Analysis
- 15.14.6 Key Developments
16. Appendix
- 16.1 About The Insight Partners
- 16.2 Glossary of Terms
샘플 요청 목록